Trial Profile
Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad Preservative (Travoprost 0.004%) Versus LUMIGAN 0.01% Solution With BAK (Bimatoprost 0.01%) in Treatment Naïve Patients With Ocular Hypertension or Open Angle Glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2015
Price :
$35
*
At a glance
- Drugs Travoprost (Primary) ; Bimatoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 23 Apr 2015 New trial record